High-intensity Resistance Training Improves Glycemic Control in Older Patients with Type 2 Diabetes
Overview
Authors
Affiliations
Objective: To examine the effect of high-intensity progressive resistance training combined with moderate weight loss on glycemic control and body composition in older patients with type 2 diabetes.
Research Design And Methods: Sedentary, overweight men and women with type 2 diabetes, aged 60-80 years (n = 36), were randomized to high-intensity progressive resistance training plus moderate weight loss (RT & WL group) or moderate weight loss plus a control program (WL group). Clinical and laboratory measurements were assessed at 0, 3, and 6 months.
Results: HbA(1c) fell significantly more in RT & WL than WL at 3 months (0.6 +/- 0.7 vs. 0.07 +/- 0.8%, P < 0.05) and 6 months (1.2 +/- 1.0 vs. 0.4 +/- 0.8%, P < 0.05). Similar reductions in body weight (RT & WL 2.5 +/- 2.9 vs. WL 3.1 +/- 2.1 kg) and fat mass (RT & WL 2.4 +/- 2.7 vs. WL 2.7 +/- 2.5 kg) were observed after 6 months. In contrast, lean body mass (LBM) increased in the RT & WL group (0.5 +/- 1.1 kg) and decreased in the WL group (0.4 +/- 1.0) after 6 months (P < 0.05). There were no between-group differences for fasting glucose, insulin, serum lipids and lipoproteins, or resting blood pressure.
Conclusions: High-intensity progressive resistance training, in combination with moderate weight loss, was effective in improving glycemic control in older patients with type 2 diabetes. Additional benefits of improved muscular strength and LBM identify high-intensity resistance training as a feasible and effective component in the management program for older patients with type 2 diabetes.
Mengistu F, Lake Y, Andualem M, Miherete Y, Zewdie S Front Physiol. 2025; 16:1519180.
PMID: 40070458 PMC: 11893990. DOI: 10.3389/fphys.2025.1519180.
Sammut M, Thorne B, Melling C Obesity (Silver Spring). 2025; 33(3):435-451.
PMID: 39948829 PMC: 11897867. DOI: 10.1002/oby.24223.
Cross-cutting effect of type 2 diabetes on the sensorimotor control of balance.
Lopatin T, Borngesser B, Haworth J Front Clin Diabetes Healthc. 2025; 5():1441947.
PMID: 39845776 PMC: 11750827. DOI: 10.3389/fcdhc.2024.1441947.
Yokoyama M, Kusuba Y, Hashizume K, Matsuura E J Rural Med. 2025; 20(1):20-27.
PMID: 39781300 PMC: 11704600. DOI: 10.2185/jrm.2024-002.
Abate H, Azage A, Zegeye A, Tsega S, Agimas M, Mekonnen H PLoS One. 2024; 19(12):e0314389.
PMID: 39630627 PMC: 11616846. DOI: 10.1371/journal.pone.0314389.